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B  lymphocyte responses appear  to involve a  number of distinct,  separately 
controlled steps. Strong evidence now exists for at least three events: (a) stimu- 
lation of a resting B cell to enter the G~ phase of the cell cycle (activationl), (b) 
commitment of this cell to proliferate and expand clonally, and (c) differentiation 
of this cell to the antibody secretory cell stage (1-5).  The first two steps can be 
stimulated  by anti-At or anti-6  antibodies,  presumably acting as  surrogates  for 
antigen  (6-8).  The  proliferative  step  requires  high  concentrations  of  these 
antibodies,  whereas  the  entry  into  G~  phase  can  be  stimulated  by  low 
concentrations  2 (4).  In this polyclonal system, B cell growth factor (now desig- 
nated BSF-pl), s a T  cell-derived lymphokine, can stimulate proliferation of cells 
incubated with this lower dose of anti-tt (9). Progression of cells to the antibody- 
secreting stage can be induced by addition of other T  cell-derived factors (3, 5, 
10, 11). 
B cell responses can also be obtained through the action of major histocom- 
patibility  complex  (MHC)4-restricted,  antigen-specific  helper  T  cells.  Several 
groups have reported achieving polyclonal stimulation of B cells by using either 
antigen-primed, MHC-restricted lymph node T  cells (12-14) or in vitro-propa- 
gated  T  cell  lines  05-17).  We  wished  to  determine  the  stage  in  the  B  cell 
response at which such T  cells expressed this function and to examine the MHC- 
restriction of B cell activation and proliferation. The use of in vitro propagated 
T  cell  lines  of known specificity provided an  attractive  approach  to this  end 
because large  numbers of specific T  cells could be added to B  cells, with the 
expectation that optimal conditions for B cell stimulation could be achieved. We 
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report here polyclonal stimulation  of resting B  cells by T  cell lines,  by T  cells 
cloned from such lines, and by cloned T  cell hybridomas. T  cells stimulated by 
antigen and antigen-presenting cells (APC) of the appropriate  MHC type were 
capable of activating essentially all resting B cells to enter G~ phase in the absence 
of antigens for which the B cells were specific. A  large fraction (~35%) of these 
cells entered S  phase and substantial  amounts of antibody were secreted.  This 
polyclonai T  cell stimulation of resting B cells was found to be MHC-unrestricted 
at  the  level of B  cell-T cell interaction.  It appears  to  represent a  mechanism 
through which resting B cells may be activated by the action of T  cells without 
occupancy of mIg and without cognate MHC-restricted T  cell-B cell interactions. 
Materials and Methods 
Reagents.  Goat anti-tt antibodies were purified by positive and negative affinity chro- 
matography procedures as described previously (8).  GAT (poly-[Glu~°Ala3°Tyrl°]n)  was 
purchased from Vega Biochemicals, Tucson, AZ, and pigeon cytochrome c was purchased 
from  Sigma  Chemical  Co.,  St.  Louis,  MO,  purified  over carboxymethyl cellulose as 
previously described (18) and generously provided to us by Dr. Lawrence Samelson of 
this laboratory. 
Mice.  BI0  MHC-congenic  strains  of mice  were  bred  as  described  (19)  and  were 
generally 2-6 months of age at time of use. BlO.xid mice were obtained from Dr. Carl 
Hansen, NIH. These mice were derived from B10.ScN mice, a lipopolysaccharide (LPS) 
unresponsive strain, into which the X chromosome from CBA/N mice was introduced as 
previously described (20). 
Cell Preparations.  Spleen cells  were incubated with  monoclonal anti-Thy-l.2 (New 
England Nuclear, Boston, MA),  monoclonal anti-Lyt-1  (53.7.3) and monoclonal anti- 
Lyt-2 (53.6.7) (21) on ice for 30-45 rain, centrifuged, resuspended in guinea pig comple- 
ment (1:4 dilution; Flow Laboratories, Rockviile, MD) containing the monoclonal mouse 
anti-rat kappa chain antibody MAR 18.5 (22), which increases the cytotoxicity of the anti- 
Lyt-1 and anti-Lyt-2 reagents, and incubated at 37°C for 30 min. Cells prepared in this 
way completely lacked proliferative Con A or mixed leukocyte responses. Following T 
cell depletion, spleen cells were fractionated on a  Percoll density gradient as described 
(23). The low density fraction (density <1.062 g/mi) was previously found to be enriched 
for macrophages (as assessed by latex bead phagocytosis) and for radioresistant APC. The 
high density fraction (density between 1.074 and 1.086 g/ml) was >80% mIg÷-celis and 
these were shown to be resting B cells by several criteria (23). Except where specified, this 
high density fraction from the Percoll gradient was used and is referred to as "B cells." 
For some experiments, B cells  were additionally purified by passage  through columns 
containing Sephadex G-10 (24) or passage through such columns followed by purification 
by adherence to and recovery from anti-#-coated petri plates (Corning 100-mm tissue 
culture-treated plates, coated with  10 ug/ml of affinity-purified goat anti-t~, 7  ml per 
plate) (25, 26).  Flow microfluorometric analysis  of these populations indicated that after 
passage over a column of Sephadex G-10, 95% of the cells were mIg+;  after recovery 
from anti-~-coated plates >99% of the cells were mIg  ÷. 
Long-term T Cells and Hybridomas.  The T  cell lines were grown as described in detail 
elsewhere  (27,  28).  The  T  cell  hybridomas used  in  this  study have  been  previously 
reported (29). Interleukin 2 (IL-2) secretion by the hybridomas was tested to ensure that 
the cells had not lost specificity after recovery from liquid nitrogen storage. 
Tissue Culture and Analysis.  Cells were cultured in Iscove's/F12 medium (30) with 10% 
fetal bovine serum. Generally, 2 ×  105 B cells were cultured with ~2 x  104 T  cells from 
T cell lines or with 1 x  105 hybridoma T cell in 96-well flat-bottom plates (Costar #3596) 
in duplicate. The T  cells were irradiated sufficiently to reduce their proliferation and 
incorporation of [SH]thymidine to insignificant levels: for 11.4 T  cells, 2,000 rads, for the 
T cell hybridomas, 10,000 rads, for other T cell clones, 3,300 rads. For Coulter counter 
(Coulter Electronics, Inc., Hialeah, FL) analysis  of cell size, cells were harvested ~24 h DEFRANCO ET  AL.  863 
after the initiation of the culture and analyzed as described previously (23). For prolifer- 
ation assays, 1 #Ci of [SH]thymidine was added to the cultures at 24 h after the start of 
culture and the incorporation of radioactivity was measured by collecting the cells, after 
42-48 h of culture, with an automated harvester (Ph.D. Harvester,  Cambridge Technol- 
ogy, Cambridge, MA) and counting the filters in a liquid scintillation counter. The period 
of time chosen for the incorporation of thymidine corresponds closely to the first round 
of replication of resting B cells stimulated with anti-# antibody (23). Similar results were 
obtained in several experiments with either a 4-h pulse of thymidine on day 2 or a longer 
pulse on day 3. [SH]Thymidine incorporation  decreased considerably by day 4. Cell cycle 
analysis by propidium iodide staining of intact nuclei from hypotonically lysed cells was 
performed as described  (23) except  that a FACS 2 (Bectin-Dickinson, Mountain  View, 
CA) was used  to  measure  fluorescence  of individual  nuclei.  The cell population  was 
divided into cells in Go or G1 phases (diploid amounts of DNA), cells in G~ or M phases 
(tetrapioid amounts of DNA) and cells in S phase (content of DNA between diploid and 
tetraploid amounts). Colcemid (25 ng/ml) was added at 24 h of culture to prevent cells 
from completing M phase, thus ensuring that only cells entering S phase for the first time 
would be counted. IgM secretion was measured after 4 d of culture by an ELISA method 
(31) using goat anti-# (50 #g/ml) to coat flat-bottom tissue culture plates (Costar #3596), 
and developing with Biotinylated-Bet 2 (a monoclonal rat anti-mouse IgM [32]) and avidin- 
horseradish  peroxidase (Vector  Laboratories,  Inc., Burlingame, CA). Optical density of 
the  wells was measured with  a  Dynatech  plate  reader.  Standard curves  with  known 
amounts of an IgM myeloma protein were used to convert absorbance into concentration 
of IgM. 
Results 
Antigen-stimulated  T Cell Lines Can Activate Resting B Cells.  Resting B cells were 
prepared from mouse spleen cells by treatment with monoclonal antibodies to T 
cell antigens and complement and by separation of the remaining cells by Percoll 
density gradient centrifugation. The most dense cells  collected (>1.074  g/ml) 
have a  median volume of 110  ums and are quite homogeneous in size.  When 
resting B cells from B10.A mice were cultured with the syngeneic cloned B10.A 
T  cell line, 11.4, and with GAT (100 #g/ml), the antigen for which 11.4 T  cells 
are specific, a prompt and dramatic increase in cell volume occurred. By 21  h, 
virtually all  of the cultured B  cells had increased in size,  typically attaining a 
mean cell volume of ~200 #m  s in the presence of 1/10 as many T  cells as B cells 
(Fig.  1).  This size  enlargement, which appears to reflect entry of Go cells  into 
the G1 phase of the cell cycle (23),  was dependent upon the presence of 11.4 T 
cells;  without  11.4  T  cells, no B  cell enlargement was observed.  B10.S(9R)  B 
Aa.A~ restriction element, for which 11.4 T  cells  cells, which do not possess the  k.  k 
are "co-specific," did not show the dramatic enlargement that syngeneic B10.A 
B cells underwent in the presence of 11.4 T  cells and GAT. In the absence of 
GAT, 11.4 T  cells caused a slight size enlargement of B cells from either B10.A 
or B10.S(9R) mice. 
B10.A B cells also entered S phase in the presence of 11.4 T  cells and GAT. 
Incorporation of [SH]thymidine by B10.A B cells in the presence of irradiated 
11.4 T  cells and GAT was considerable and often comparable to that stimulated 
by lipopolysaccharide (Table I). The magnitude of the response of B10.A B cells 
was a function of the number of 11.4 cells present and had not reached maximal 
plateau values even at a ratio of 4 B cells for each T  cell (i.e., 2 x  105 BI0.A B 
cells and 5  x  104  11.4  T  cells).  Analysis of the fraction of B  cells  entering S 
phase  for  the  first  time,  using  propidium  iodide  staining of isolated  nuclei, 864  POLYCLONAL  B  CELL  STIMULATION 
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FIGURE  1.  B cell enlargement caused by antigen-stimulated T  cells. B10.A and BI0.S(9R) 
resting B cells (1  x  106 in  1 ml) were co-cultured for 21  h  alone, with 11.4 T  cells or with 
11.4 T  cells and GAT (100 #g/mi) and the cell size distribution of the population and median 
size was measured with a Coulter Counter and channelyzer. Ratios refer to the relative number 
of B  to  T  cells.  Cell  size  distributions are  shown  for  B10.A  B  cells;  median  cell  volume 
measurements are presented, in tabular form, for B10.A and B10.S(9R) B cells.  Only 5-10% 
of the cells in culture were l 1.4 T  cells; thus, most of the profile is due to B cells. 
MEDIAN SIZE (t.an  "~) 
TABLE  I 
B Cell Proliferation Induced by Antigen-stimulated T Cells 
[SH]Thymidine incorpora- 
B cells  Stimulant  tion (cpm) 
Expt.  1  Expt. 2 
None  11.4 T  cells  500  -- 
11.4 T  cells +  GAT  350  -- 
B10.A B cells  0  4,200  2,500 
LPS  130,000  128,000 
11.4 T  cells  12,800  14,500 
11.4 T  cells plus GAT  69,500  101,000 
BI0.RIII B cells  0  3,900  6,900 
LPS  115,000  124,000 
11.4 T  cells  38,100  50,300 
11.4 T  cells plus GAT  29,400  69,700 
B10.A or B10.RIII B cells (2 x  10S/well), were cultured with nothing, LPS (50 t~g/ml), 
or 2  x  104  11.4 T  cells (irradiated at 2,000 rads) with or without GAT (100 #g/ml). 
[SH]Thymidine incorporation was measured as described in Materials and Methods. 
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indicated  that 35%  of cells surviving  48  h  in cultures containing colcemid  (25 
ng/mi) had entered S phase in response to 11.4 T  cells and GAT at a ratio of 1 
T  cell for every  10 B cells (Table II).  These results demonstrate the polyclonal 
nature of the B cell proliferation. 
Other  T  cell  lines  and  T  cell  hybridomas  also  expressed  the  capacity  to 
stimulate  resting  B  cells  to enter  S  phase.  These  included  B10.A-drived  lines 
specific for antigen in association with syngeneic  Ia molecules and lines specific 
for allogeneic  Ia  molecules.  Table  III  presents  results  from  experiments  with 
four  B10.A  T  cell  lines  specific  for  cytochrome  c  and  the  k.  k  Ea.E~ restriction 
Aa.A~  restriction  element  and  one  additional  line  specific  for  GAT  and  the  k.  k 
element.  We  have  also  observed  that  three  of  four  antigen-specific  T  cell 
TABLE  II 
Entry into S Phase of Resting B Cells Cultured with 11.4 T Cells and GAT 
No. added T  No stimulant: % of  A % of cells entering S 
cells  cells entering S  GAT  GAT +  anti-/* 
0  (10.6)  --  6.0 
2 x  104  (8.8)  5.6  47.8 
5 x  104  (11.4)  11.2  49.6 
1 x  105  (10.2)  35.0  58.1 
B10.A B cells (1  x  10  °) were cultured with varying numbers oi  r 11.4 T  cells in 
the presence or absence of GAT (100/*g/ml) and anti-/* (2/*g/ml). Colcemid (25 
ng/ml) was added  at 24  h  and nuclei stained at 48  h  with propidium iodide. 
Fluorescence measurements of nuclear DNA content were made on the FACS 
II; percent of cells in S, G,, and M phases were summed to give percent of cells 
entering S phase for the first time (23). Results in parentheses indicate absolute 
percent of cells entering S phase in the absence of GAT or anti-/,. Other entries 
represent the increment in percent of cells in S phase (A percent). 
--, not done. 
TABLE  III 
Stimulation of Proliferation of Allogeneic and Syngeneic B Cells By Antigen-activated T Cell 
Clones 
Expt. 
Syngeneic B cells  Allogeneic B cells +  irrad, syngeneic APC 
T  cells  Antigen:  MHC type  Antigen: 
No.  and no. of B  APC  -  +  -  + 
cells 
1  A.5.1  1 x  105  240  16,900  v; I  X 105  2 x  104  200  19,100 
2  PC.3.3  2 x  105  12,400  29,300  b; 2 x  105  2 x  105  16,300  36,000 
3  PC.1B  2 X 105  5,500  38,300  i18; 2 X  105  2 x  10  ~  8,300  17,100 
4  PC.3L  1 x  105  1,100  15,200  i18; 1 x  105  1 x  105  1,600  6,700 
PC1.K  1 x  105  1,100  11,700  t4; 1 x  105  1 x  105  1,300  6,600 
Responding  syngeneic  (BI0.A)  or  allogeneic  (B10.Sm,  H-2*;  B10,  H-2b;  B10.A(18R),  H-211s; 
B10 S(9R), H-2  '4) B cells (1  x  105 or 2 x  105) were cultured with 2  x  104 T  cells (3,300 fads) with 
no antigen,  with GAT  (100 #g/ml;  A.5.1) or with pigeon  cytochrome c (PC.3.3,  PC.IB,  PC.3L, 
PCI.K).  Antigen-presenting cells added  to allogeneic B  cells were Sephadex G-10-passed B  cells 
(1,000 fads) in each case except in Expt.  1 were 3,300 tad-treated low density cells, obtained from 
Percoil separation, were used. Results are expressed as cpm of [SH]thymidine incorporation at 48 h 
of culture. 866  POLYCLONAL  B  CELL  STIMULATION 
hybridomas (see reference 19)  are capable of causing polyclonal responses by 
syngeneic resting B cells when the T  cells are stimulated by antigen. 
11.4 T  cells cultured with GAT and B10.A B cells also caused B10.A B cells 
to differentiate into IgM-secreting cells (Table IV). This was assessed by meas- 
uring the amount of IgM in the supernatant on day 4 of such cultures. Maximal 
IgM secretion was obtained in the presence of l0 s 11.4 T  cells, which is far less 
than the number of 11.4 T  cells that elicited maximal proliferation of B10.A B 
cells (see below).  The failure to  observe significant amounts of IgM  secretion 
when numbers of 11.4 T  cells optimal for B cell proliferation were used might 
represent a  depletion of nutrients from culture since the degree of thymidine 
incorporation on day 4,  the day when IgM synthesis was measured, was much 
less  than  at  days  2  or  3.  Alternatively,  it  may reflect an  inability  of rapidly 
proliferating cells to differentiate. 
It is very unlikely that the activation of resting B cells in these cultures and 
their entry into  S  phase  depends upon  the presence of antigen(s) capable  of 
binding to their mIg receptors, since virtually all the resting cells enter G1 phase 
and a  considerable proportion  enter S  phase.  It can hardly be expected that 
antigens complementary to receptors of all B cells are present in these cultures. 
Stimulation  of Resting B  Cells Does Not Require  That  They Participate  in MHC- 
TABLE  IV 
IgM Secretion of B Cells Stimulated by Antigen-activated 11.4 T Cells 
IgM secreted by day 4 (ng/culture) 
Addition  B 10.A B cells:  B 10.S(9R)  B cells: 
+GAT  -  +GAT 
Expt. 1 
None  100  150 
LPS  >5,850  2,000 
11.4, 
1 X 102  190  190  140  220 
3 X l0  s  170  780  200  530 
I  x  10  s  200  1,900  300  520 
3 X l0  s  240  1,700  620  1,300 
1 x  104  240  160  510  8 
3 x  104  200  30 
Expt. 2 
None  25  95 
LPS  _>4,400  ->4,400 
11.4, 
5 x  103  560  1,600  220  >_4,400 
1 x  104  110  570  300  3,500 
2 x  104  230  200  230  1,300 
5  x  104  250  40  1,170  770 
B cells were incubated in triplicate at 2  x  105 cells/well with additions noted above. 
Culture fluids were analyzed for IgM content on day 4 of culture by the ELISA method 
(31).  In every case, the standard deviation was <50% of the value. In Expt. 1 B10.A B 
cells, 7 x  10  ~, irradiated at 1,000 rads, were added to cultures containing B10.S(9R) B 
cells as a source of antigen-presenting  cells; in Expt. 2, B 10.A low density cells 5 X 104, 
irradiated at 1,000 rads, were added. When these irradiated cells were incubated alone 
with either LPS or with 11.4 and GAT, they did not secrete significant levels of IgM. DEFRANCO  ET  AL.  867 
restricted Interactions  with T Cells.  B cells from B 10.S(9R), B 10, B 10.D2, or other 
k  k  non Aa:A~ bearing stains of mice cultured with  11.4 T  cells and GAT failed to 
enlarge or to incorporate [3H]thymidine. This might reflect a failure of I 1.4 T 
cells to activate these B cells because stimulated  11.4 T  cells cannot collaborate 
with allogeneic B cells and/or because  11.4 T  cells are not stimulated by GAT 
in  the  absence of a  source of A~:A~-bearing  APC.  To examine  this  issue,  we 
studied B 10.S(9R) B cell activation in cultures containing  B10.BR (A~:A~-bear- 
ing) B cells,  11.4 T  cells, and GAT.  To measure B cell activation,  we assessed 
the enlargement  of both the B10.S(9R) and B10.BR B cells, using flow micro- 
fluorometry, by measuring the degree of forward light scatter of cells that were 
fluorescence  positive  or  that  were  fluorescence  negative  when  stained  with 
fluoresceinated (F1)  15-5-5, a  monoclonal antibody that  binds to cells bearing 
H-2K  d or H-2D  k gene products (33) (i.e.,  binds to B10.BR but not B10.S(9R) 
cells). When B10.S(9R) B cells were cultured with  11.4 T  cells and GAT for 24 
h, no increase in forward light scatter was observed, while B 10.A B cells cultured 
with  11.4  T  cells and  GAT showed substantial  increase  in  their  forward light 
scatter histograms. This is illustrated in Fig. 2 B, in which the two cell types were 
mixed after culture and the forward light scatter histograms of the fluorescence- 
positive (B10.BR) and fluorescence-negative (B10.S(9R)) B cells in the mixture 
were measured. By contrast, when the B 10.A and B 10.S(9R) B cells were mixed 
and  then  cultured  with  11.4  T  cells  and  GAT,  both  fluorescence-positive 
(B10.BR)  and  fluorescence-negative  (B10.S(9R))  B  cells  displayed  equivalent 
increases in the magnitude of their forward light scatter (Fig. 2 A). This increase 
in  forward  light  scatter was dependent  upon  11.4  T  cells and  GAT (data  not 
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FIGURE 2.  Stimulation of enlargement of allogeneic B cells by 11.4 T  cells in the presence 
of syngeneic B cells and GAT. B10.BR (15-5-5  +) B cells were mixed with B10.S(9R) (15-5-5-) 
B cells either before (A) or after (B) culture for 20 h in the presence of 11.4 T  cells (B cell/T 
cell ratio 10:1) and GAT (100 #g/ml). B cells were cultured at a  total density of 2  x  106/ml 
in each case.  Cells were stained with F1-15-5-5. Forward light scatter and fluorescence data 
were collected on each cell using a FACS 2. Forward light scatter profiles of the fluorescence- 
positive (B 10.BR) cells and of the fluorescence-negative (B 10.S[9R]) cells were obtained. Cells 
were  also  stained  with  fluorescence-labeled  anti-/,  to  demonstrate  that  the  profiles  were 
primarily due  to  B  cells (not shown).  The  forward  light scatter profiles of BI0.S(9R)  and 
B10.A B  cells mixed after culture (B) were equivalent to the profiles of similarly cultured 
B10.S(9R) and B10.A B cells analyzed separately (data not shown). 868  POLYCLONAL  B  CELL  STIMULATION 
shown).  Since  forward  light  scatter  is  a  function  of cell  volume,  this  result 
indicates that B 10.S(9R) B cells enlarge in the presence of B10.BR B cells, 11.4 
T  cells, and GAT.  Presumably, B10.A  B  cells present GAT  to  11.4  T  cells, 
stimulate them, and they in turn activate B10.S(9R)  B cells in an MHC-unre- 
stricted manner. 
Although B10.S(9R) B cells do not proliferate in the presence of irradiated 
11.4 T  cells and GAT, the addition of B10.A B cells irradiated at 1,000 rads, as 
a  source of APC, resulted in [3H]thymidine incorporation by the allogeneic B 
cells.  The  magnitude  of this  response  was  dependent  upon  the  number  of 
irradiated B10.A B cells added and was quite substantial in the presence of 1-3 
x  105 irradiated B10.A B cells (Fig.  3). Comparison of [~H]thymidine incorpo- 
ration by B10.A and B10.S(9R) B cells in the presence of different numbers of 
11.4 T  cells revealed that the B10.S(9R) cells required two- to threefold more 
T  cells than did syngeneic cells to achieve equivalent responses (Fig. 4). 
Incorporation  of [aH]thymidine by  B10.S(9R)  B  cells also  occurred in  the 
presence of 11.4 T  cells stimulated with GAT in the presence of T  cell-depleted 
unfractionated B10.A spleen cells irradiated at 3,300 rads or in the presence of 
a macrophage- and dendritic cell-rich low density (<1.062 g/ml) cell fraction. A 
detailed comparison of the relative effectiveness of irradiated resting B  cells, 
macrophage-rich cell populations,  and whole spleen cells to  stimulate  11.4  T 
cells for "recruitment" of B10.S(9R) B cell activation and proliferation and for 
stimulation  of proliferation  of  11.4  T  cells,  themselves,  is  presented  in  the 
companion paper  (19).  We  note  here  that,  in  the  presence of GAT,  highly 
purified high density B10.A B cells are at least as effective, on a per cell basis,  as 
either of the other cell populations for causing 11.4 T  ceil-dependent B 10.S(9R) 
B cell proliferation provided the B cells are irradiated at 1,000 rads or less. 
The ability to cause proliferation of allogeneic B cells when examined in this 
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way was not a  unique property of 11.4  T  cells, but rather was found to be a 
general property of antigen-specific T  cell clones that could stimulate prolifera- 
tion of syngeneic B cells. Experiments with other B10.A T  cell clones are shown 
in Table III. As already described, all five lines, when irradiated, caused consid- 
erable proliferation of syngeneic B cells in the presence of the antigen for which 
the T  cells were specific. Addition of T  cells and antigen caused proliferation of 
allogeneic B  cells,  provided  that  irradiated  B10.A  APC  were added.  In  this 
situation,  the presence of antigen and functional APC  stimulated each of the 
cloned T  cells to cause significant [3H]thymidine uptake by ailogeneic B cells. 
B10.S(9R) B cells, co-cultured with irradiated B10.A B cells, 11.4 T  cells, and 
GAT also differentiate into Ig-secreting cells by day 4 (Table IV). The optimal 
number of 11.4 T  cells for this differentiation is 3 x  103 cells, considerably less 
than  the  optimal  number  for  B  cell  proliferation, just  as  was  true  of  the 
differentiation of syngeneic B 10.A B cells. 
B Cells from "xid" Mice Can Stimulate and Respond to 11.4 T Cells.  B cells from 
mice  with  the  xid-determined  defect (xid  B  cells)  have been  reported  to  be 
capable of interacting with T  cells in an  MHC-restricted manner in order to 
differentiate into Ig-secreting cells, but to fail to respond in non-MHC-restricted 
T  cell-B cell interactions (34). We tested the ability of xid B cells to proliferate 
when co-cultured with  11.4  T  cells and GAT,  both when these cells bore the 
A~:A~-restriction element and when they lacked it. B cells from (CBA/N X DBA/ 
2)F1 male mice, which have the xid-determined defect and express A~:A~, showed 
excellent [3H]thymidine incorporation  in  response  to  11.4  T  cells and  GAT 
(Table V). These responses were greater than those stimulated by LPS and were 
not further enhanced by addition of 1,000-rad irradiated B10.A B cells. Although 870  POLYCLONAL  B  CELL  STIMULATION 
TABLE  V 
Proliferation of xid B Cells in Response to Antigen-stimulated T Cells 
Addition  (DBA/2 x  CBA/N)Fz  (CBA/N x  DBA/2)FI  BI0  Bl0.xid 
GAT:  -  +  -  +  -  +  -  + 
[S  H ]Thymidine  incorporation (cpm ) 
None  4,300  3,000  2,900  2,000 
LPS  114,000  61,700  32,200  7,000 
Con A  4,000  1,500  1,800  2,000 
I 1.4 T  9,200  141,000  2,600  95,200  5,600  4,600  4,400 
BI0.A, B Cells  8,200  136,000  2,600  87,300  3,600  60,100  5,400 
+  11.4 T  Cells 
4,700 
37,000 
B cells were  incubated at 2 x  10  s cells/well with additions as shown and their incorporation of [SH]thymidine  measured  after 48 h of culture. 
2 x  104 2,000 rad-treated  11.4 T  cells were  added where indicated.  7 ×  104 irradiated (1,000  rads)  B10.A (B10.Ax) B cells were added to 
cultures as indicated as a source  of APC.  These irradiated B cells did not incorporate significant  amounts of [SH]thymidine, (DBA/2 x  CBA/ 
N)FI and (CBA/N x  DBA/2)FI B ceils were derived from male donors. The former are phenotypically  normal; the latter express  the xid- 
determined defect. 
the  response  of  B  cells  from  (DBA/2  x  CBA/N)F1  male  mice,  which  are 
phenotypically normal,  was somewhat greater than those of the xid B cells, this 
may simply reflect the superior survival of the normal cells in culture. 
Ao.A, restriction  element  to be  The  capacity of xid  B  cells that  lacked  the  k.  k 
stimulated  by  11.4  T  cells was examined  by using  BlO.xid  (H-2  b) B  cells and 
comparing them to C57BL/10 SgSn B cells. Neither B cell population incorpo- 
rated  [3H]thymidine  in  the  presence  of  11.4  T  cells  and  GAT;  addition  of 
irradiated  B10.A B cells as a source of APC caused substantial proliferation  on 
the part of both cell populations.  As with the syngeneic B cells, the response of 
xid B cell was about one-half of the response of normal  B cells (Table V). The 
meager response of the BlO.xid B cells to LPS is, at least in part, due to the fact 
that  they are  derived from the  LPS-unresponsive  strain  C57BL/10  ScN.  The 
control mice, C57BL/10 SgSn, are normally responsive to LPS. 
These results indicate that  B cells from xid mice are competent to stimulate 
11.4 T  cells in the presence of GAT and capable of being recruited, in an MHC- 
unrestricted manner,  to enter S phase. 
Anti-IgM Antibodies Synergize with 11.4 T Cells in B Cell Activation.  Thus far we 
have shown that essentially all B10.A B cells will enter the GI phase of the cell 
cycle in the presence of 11.4 T  cells and GAT. Antigen(s) capable of binding to 
the B cell's mIg do not appear to be required for this activation. Similarly, many 
of these B cells also enter S phase in such cultures.  We have previously shown 
that low concentrations of anti-# (1 or 2 #g/ml) cause virtually all resting B cells 
to enter Ga  phase but very few to enter S phase (9).  Some of these Gl  B cells 
enter S phase in the presence of BSF-pl (10, unpublished observations). 
We  next  examined  the  effect  of addition  of 2  #g/ml  of anti-#  to  cultures 
containing B 10.A B cells,  11.4 T  cells, and GAT (Table II). Our results indicate 
that when limiting numbers of 11.4 T  cells are present,  anti-# causes a striking 
enhancement in entry of B cells into S phase. Thus, co-culture of 106 B10.A B 
cells with 2 ×  10 4  11.4 T  cells (50:1 ratio) and GAT caused only 5.6% of the B 
cells to enter S phase.  In other experiments,  it was shown that  2  ×  104  11.4 T 
cells caused very limited B cell size enlargement (median cell volume at 24 h of 
124 #m 3 with control of 120 #m3).  Culturing  1 ×  106 B10.A B cells with 2 #g of 
anti-IgM caused striking size enlargement but stimulated only 6.0% of the cells DEFRANCO  ET  AL.  871 
to enter S phase.  When 2 #g of anti-IgM alone was added to cultures of 106 B 
cells, 2 x  104 11.4 T  cells and GAT, 47.8% of the cells were stimulated to enter 
S phase; this is 36.2% more than the sum of the numbers of B cells that entered 
S phase in the separate cultures. The results suggest that anti-# enhanced entry 
of B10.A cells into  G1  and  that  stimulated  11.4  T  cells,  perhaps  by secreting 
BSF-pI, caused the G~ cells to enter S phase. This also suggests that  11.4 T  cells 
use separate signals to initiate entry of B10.A B cells into the G~ and S phases, 
with the activation signal being limiting under these culture conditions. 
Stimulation of 11.4 T  Cells by B IO.RIII Cells Leads to an Apparent MHC-restricted 
B Cell Stimulation.  We have shown that 11.4 T  cells stimulated with GAT in the 
presence of a source of A~:A~-bearing cells caused the enlargement,  entry into S 
phase, and differentiation of both syngeneic (B10.A) and allogeneic (B10.S(9R)) 
B cells. It would seem reasonable to conclude that the T  celI-B cell interaction 
leading to B cell stimulation is not MHC-restricted, while the stimulation of the 
T  cells is restricted. However, further examination of B cell responses mediated 
by 11.4 T  cells revealed a situation in which B cell stimulation did appear to be 
restricted. 
Aa:A~  restriction  In  addition  to  proliferating  in  response  to  GAT  and  the  k  k 
element,  11.4 T  cells can be stimulated to proliferate by allogeneic H-T-encoded 
molecules expressed on  B10.RIII  cells, although  this alternative  stimulation  is 
considerably weaker (data not shown). Furthermore, B10.RIII B cells co-cultured 
with  11.4 T  cells, without GAT, are stimulated to enlarge (mean volume at 24 
h of 152/~m 3) and to incorporate  [3H]thymidine (Table I).  Although  B10.RIII 
B cells require approximately threefold more 11.4 T  cells than do B10.A B cells 
(in  the  presence  of  100  #g/ml  of GAT)  for  equivalent  B  cell-proliferative 
responses, the maximal  response obtained with B10.RIII B cells is only slightly 
less than  with B10.A B cells cultured  with the same number of 11.4 T  cells in 
the presence of GAT (Fig.  4).  In  contrast,  11.4 T  cells stimulated  either with 
1,000-rad  irradiated  B10.RIII  B cells (1  ×  104  to  5  X  l0 p) or with  3,300-rad 
irradiated  B10.R III low density cells were ineffective at stimulating [~H]thymi- 
dine incorporation  by the  B10.S(9R) B cells (Fig.  3).  In  the same experiment, 
B10.S(9R) B cells co-cultured with  irradiated  B10.A B cells,  11.4  T  cells, and 
GAT were strikingly stimulated.  Indeed,  1 x  10 4 irradiated  B10.A B cells were 
superior to 5 ×  10  ~ irradiated B 10.RIII B cells in causing 11.4 T  cells to stimulate 
B10.S(9R)  B cells to enter  S phase  (Fig.  3).  This  difference in  the  capacity to 
cause  11.4  T  cell-dependent  stimulation  of B10.S(9R) B cells is much greater 
than the two- to threefold difference in the proliferative responses of B10.A and 
B10.R III B cells stimulated by 11.4 T  ceils (Fig. 4). 
This  discrepancy  might  reflect a  qualitative  or a  quantitative  difference  in 
stimulation of 11.4 T  cells by B10.RIII B cells as compared with B10.A B cells 
and antigen.  That  is,  B10.RIII  B cells might  only be able to stimulate  11.4  T 
cells to engage in MHC-restricted B cell responses, while B10.A B cells, together 
with  GAT,  might  cause  11.4  T  cells  to  produce  nonspecific  soluble  factors 
capable of stimulating B cells without reference to their MHC type. Alternatively, 
B10.RIII  B cells and B10.A B cells plus GAT might both stimulate production 
of nonspecific  activating  factors by  11.4  T  cells,  but  the  former  might  cause 
production of smaller amounts, sufficient to stimulate only those B cells in close 872  POLYCLONAL  B  CELL  STIMULATION 
proximity  to  the  11.4  T  cells.  This  would  markedly favor the activation  of 
B10.RIII B cells, which in the course of presenting Ia  r molecules to 11.4 T  cells 
are physically linked to them, over the activation of B10.S(9R)  B cells, which 
would be  randomly distributed  in  regard to  11.4  cells.  If this  explanation  is 
correct,  we  might  anticipate  that  diminishing  the  degree  of stimulation  of 
individual 11.4 T  cells by B10.A B cells plus GAT might lead to an advantage 
in the stimulation of B10.A over B10.S(9R) B cells. We tested this by comparing 
the concentrations of GAT required to cause [3H]thymidine incorporation by 
B10.A  B  cells,  when  cultured with  irradiated  11.4  T  cells  only,  with  those 
required to stimulate B 10.S(9R) B cells co-cultured with irradiated B10.A B cells 
and 11.4 T  cells. We found that two- to fourfold higher concentrations of GAT 
were required to cause degrees of [3H]thymidine incorporation by B10.S(9R) B 
cells comparable to that  of B10.A  B  cells and that at  50  #g GAT/ml, a  very 
substantial preference for stimulating syngeneic B cells was observed (Fig. 5). 
Discussion 
These experiments demonstrate the ability of T  cell lines to cause many, if not 
all, resting B cells to enter G~ phase, proliferate, and secrete large amounts of 
antibody. These T  cell-mediated responses were displayed by B cells of different 
MHC genotypes, provided that the T  cells were optimally stimulated by antigen 
in the context of APC bearing syngeneic Ia molecules. For this purpose, syngeneic 
resting  B  cells  were as  efficient at  antigen  presentation  as  were populations 
enriched for macrophages and dendritic cells (19). The response of allogeneic B 
cells were comparable to these of syngeneic B cells, provided substantial numbers 
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FIGURE 5.  Concentration  of GAT  required  to  stimulate  proliferation of syngeneic and 
allogeneic B cells.  1 x  105 B10.A B cells or 1 x  105 irradiated B10.Ax  B cells (BI0.A~;  1,000 
rads) and 2  x  105 B10.S(9R)  B cells were cultured with 2  x  104  11.4  T  cells and varying 
concentrations  of GAT. Proliferation was assessed by incorporation of [SH]thymidine between 
24 and 48 h of culture. DEFRANCO ET AL.  873 
of syngeneic B cells or macrophages were present, presumably to serve as APC 
for the T  cells, and provided that high concentrations of antigen were used to 
stimulate the T  cells (Fig. 5). 
Resting B cells could be driven to proliferate by most of the IL-2-secreting T 
cell hybridomas tested, by all of the tested T  cell lines including cloned lines 
propagated  by alternating cycles of growth and  rest,  and by one T  cell  line 
isolated by cloning in soft agar, followed by continuous growth on IL-2 without 
antigen or accessory cells (28). Therefore, the ability of in vitro T  cells lines and 
hybridomas to  stimulate B  cells as reported here is not a  rare or uncommon 
property of T  cells,  but  rather  seems to  be  typical  of many in  vitro  T  cells 
maintained by different growth techniques. 
Recent work  with  T  cell-derived lymphokines such as  BSF-pl  (9,  35)  and 
other growth and differentiation factors (36-40) suggests possible mechanisms 
by which the T  cells used in this work might have caused some of the responses 
observed. Previous experiments had not revealed, however, the existence of a T 
cell-derived factor capable of acting on resting B cells and stimulating them to 
enter and progress through Gl phase of the cell cycle. Anti-u previously has been 
shown to perform this activation step (4), suggesting that some antigens with the 
ability  to  cross-link  mIg  might  be  able  to  do  this  as  well.  The  experiments 
presented  in  this  paper  clearly  demonstrate  that  T  cells  can  stimulate  this 
activation step  under the appropriate  circumstances, without requirement for 
occupancy of B cell antigen receptors or interaction with B cell Ia  molecules. 
Synergy was  seen  between antigen-stimulated  11.4  T  cells and  anti-~  in  the 
stimulation of B cell proliferation (Table II). At suboptimal numbers of 11.4 T 
cells,  B  cell enlargement was  slight,  suggesting little if any movement of the 
resting B cells from Go to G1. Low concentrations of anti-# caused excellent size 
enlargement of resting  B  cells,  but  induced few cells to  enter  S  phase  (23). 
Adding both  small numbers of 11.4  T  cells and low concentrations of anti-u 
caused very substantial numbers of B cells to enter S phase. This result suggests 
that the 11.4 T  cells are more efficient at causing G~ phase B cells to proliferate 
than at causing resting B cells to enter G1 phase. If this is a common property of 
helper T  cells, then under suboptimal conditions, any agent that caused a resting 
B cell to enter G~ phase, such as anti-# or, possibly an antigen capable of cross- 
linking mIg on  the B  cell surface, would promote the B  cell response to  the 
antigen-stimulated helper T  cells. 
MHC-restricted  Vs.  MHC-unrestricted  Activation.  The conclusion that antigen- 
stimulated T cells can polyclonally stimulate resting B cells to enlarge, proliferate, 
and differentiate to antibody-secreting cells in an MHC-unrestricted manner is 
surprising in view of most previous in vitro studies of helper T  cell stimulation 
of B cells. The bulk of those studies, both examining specific antibody production 
(2,  17,  34,  41,  42) and polyclonal stimulation of [~H]thymidine incorporation 
and Ig secretion with either T  cells obtained from antigen-primed donors (12- 
14) or more recently with antigen-specific T  cell lines (15-17, 42), demonstrated 
a  requirement  for  an  MHC-restricted  step.  Some  stimulants,  such  as  sheep 
erythrocytes or high concentrations of hapten-carrier conjugates are capable of 
stimulating "bystander" B cells in the presence of T  cells (43) or can stimulate 
responses  in  the  apparent  absence  of T  cells  if T  cell-replacing factors are 874  POLYCLONAL B CELL STIMULATION 
provided (3).  However, whether resting B cells are the responsive cells in these 
circumstances has not been shown.  We believe that  the results presented here 
conclusively demonstrate that helper T  cells can activate and stimulate prolifer- 
ation of B cells by an MHC-unrestricted mechanism,  even in the absence of the 
antigen recognized by the B cell. 
There are several possible explanations for the differences between our results 
and those results emphasizing the need for MHC-restricted T  cell-B cell inter- 
action.  One possibility is that all helper cell activation of B cells is unrestricted 
and that apparent  MHC restriction is the result of suboptimal T  cell activation 
or of the use of helper cell populations that are limited in the amount of factor(s) 
they can produce. For example,  11.4 T  cells in the presence of 100 ~g/ml GAT 
and lightly irradiated  B 10.A B cells stimulated the proliferation of allogeneic B 
cells. However, at suboptimal concentrations (e.g.  50 ug/m]) of GAT, B10.A B 
cells were preferentially  stimulated  to  a  striking  extent.  This  effect was even 
more dramatic when  11.4 T  cells were stimulated with B10.RIII cells. B 10.RIII 
antigen-presenting  cells are  10-30-fold  poorer  at  stimulating  proliferation  of 
11.4 T  cells compared with B10.A APC in the presence of 100 t~g/ml GAT (data 
not shown).  11.4 T  cells were capable of causing B10.RIII stimulator B cells to 
proliferate vigorously. However, bystander B10.S(9R) B cells were not induced 
to proliferate  in  the presence of 11.4 and  lightly  irradiated  B10.RIII  B  cells. 
This is in striking contrast to the observation that the same bystander B10.S(9R) 
B cells proliferated quite well in the presence of 11.4 T  cells and lightly irradiated 
B10.A B cells plus GAT. A possible explanation for these results is that B10.RIII 
cells stimulate the 11.4 T  cells less intensely than do B10.A B cells and GAT and 
that the stimulation by B10.RIII cells leads to release of B cell activating factor(s) 
by  11.4 T  cells in  correspondingly  lower amounts  than  would be produced in 
response to stimulation by B 10.A B cells and high concentrations of GAT. These 
lower amounts of factor(s) might  be sufficient only to activate  B cells that  are 
quite close to the 11.4 T  cells. B10.RIII B cells would be activated, according to 
this explanation,  because they have presented antigen  (i.e.,  Ia  r) to  11.4 T  cells 
by physically interacting with them and therefore are very close to the source of 
the B cell activating factor(s). The  bystander cells are,  on the average,  farther 
away, and therefore are not activated nearly as well.  Similarly,  when B10.A B 
cells and  lower concentrations  of GAT are  used,  11.4  T  cells are  stimulated 
relatively poorly and a  similar preference for syngeneic responses occurs. This 
explanation suggests that polyclonal stimulation of B cells by helper T  cells such 
as  that  reported  from  our  laboratory by Tse  et al.  (12) and  by Marrack  and 
Kappler (13) or by T  cell lines such as seen by Coutinho (15) and Ratcliffe et al. 
(16) may be the result of an unrestricted mechanism that only operates at a short 
distance from the helper T  cell. In such cases, syngeneic B cell responses would 
be favored because T  cells would recognize  and  bind  to antigen  and  class  II 
molecules on the surface of syngeneic B cells. 
A similar argument could explain apparent MHC restriction in antigen-specific 
antibody responses. When high doses of antigen are used (e.g.  100 #g/ml), many 
cells in the culture can present antigen and the magnitude of T  cell response is 
great,  leading  to  production  of large  amounts  of activating  factor(s)  and  to 
nonrestricted B cell activation. On the other hand,  when lower antigen concen- DEFRANCO  ET  AL.  875 
trations are used one might expect that only the antigen-specific B cell would 
bind sufficient antigen, via its membrane immunoglobulin, to act as an antigen- 
presenting B cell. Such a possibility has been graphically illustrated by Hedrick 
and Schwartz (44),  who found that T  cells specific for IgG2a allotypes could 
respond to a  1,000-fold lower concentration of antigen if the IgG2a was specific 
for and reacted with molecules on the surface of APC. Alternatively, the principal 
APC in such cultures may be macrophages and other Ia-bearing cells, such as 
dendritic cells. Indeed, in most experiments of this type, responses are reported 
to  be  macrophage dependent.  Under such  circumstances, when  low  antigen 
concentrations are used, each T  cell is stimulated relatively poorly (i.e., by APC 
bearing small amounts of antigen). Such T  cells would be expected to produce 
small amounts of activating factor(s). Syngeneic B cells, specific for the antigen 
that stimulated the T  cells, would be bound by the responding T  cells because 
those T  cells would recognize the antigen and the restriction elements on the B 
cells.  This  would  lead  to  activation  of antigen-specific syngeneic B  cells.  In 
contrast, neither allogeneic antigen-specific B cells nor syngeneic non-antigen- 
specific B cells would interact with the T  cells. The former would fail to interact 
because, although they would have bound antigen to their receptors, they do 
not display a restriction element for which the T  cells were co-specific. The latter 
cells would fail to interact with T cells because, although they express the proper 
restriction elements, they fail to capture sufficient antigen on their membrane 
when low concentrations are used since their receptors are not specific for that 
antigen. Of course, allogeneic B cells lacking receptors for the antigen in question 
would present neither the appropriate restriction element nor the proper antigen. 
This would lead to a situation in which antigen-specific B cells bearing class  II 
molecules syngeneic to the T  cells would be preferentially activated; that is, to 
an  MHC-restricted  T  celI-B  cell  interaction.  Furthermore,  in  hapten-carrier 
systems  in  which  carrier-specific  T  cells  are  used  and  anti-hapten  antibody 
responses are measured, cellular interactions could be achieved only if the hapten 
and carrier were linked to one another. 
The results of Asano et al. (34) fit this scenario fairly well. They found that 
stimulation of B cells by cloned in vitro T  cell lines was not MHC restricted at 
high  antigen  concentrations,  but  was  restricted and  required  hapten-carrier 
linkage at  low antigen concentrations.  An apparent discrepancy between our 
results and theirs is that Asano et al.  (34) found that xid B cells could not be 
stimulated to become hapten-specific antibody-producing cells in a  non-MHC- 
restricted manner when high antigen concentrations were used. In our experi- 
ments, allogeneic xid B cells proliferated -50% as well as did allogeneic B cells 
from normal mice in the presence of irradiated syngeneic B cells,  11.4 T  cells, 
and antigen. A  possible reason for this difference may be that antigen-specific 
responses in  cultures receiving high antigen concentrations may require very 
substantial relative expansion of hapten-specific clones. Receptor cross-linkage 
by antigen could cause such expansion by making B cells sensitive to BSF-pl; xid 
B cells fail to proliferate in response to anti-~ together with BSF-pl, suggesting 
that they would not display such clonal expansion. This could lead to the striking 
difference reported in antigen-specific antibody responses of normal and xid B 
cells when high antigen doses are used. By contrast, we would predict that in 876  POLYCLONAL  B  CELL  STIMULATION 
such  systems  measurement of total  Ig  production  would  reveal  little  or  no 
difference between normal and xid B cells because receptor cross-linked stimu- 
lation of clonal expansion would play a  lesser role in total Ig synthesis in such 
cultures. 
Although nonspecific activating factors produced by stimulated T  cells may 
explain many examples of MHC-restricted B cell stimulation, it does not rule out 
the possibility that activation mediated by truly MHC-restricted mechanisms does 
exist.  Indeed, there are reports of MHC-restricted helper factors (45,  46) and 
allogeneic effect factor (AEF) has many of the properties one would expect of 
an MHC-restricted factor (47). Such factors are believed to act early in the B cell 
response, although that has not been demonstrated directly. Stimulation of B 
cells by some helper T  cells may involve this  putative  MHC-restricted event, 
whereas other T  cells,  such as the in  vitro lines and hybridomas used in  this 
work, may be capable of releasing additional factors that bypass this requirement. 
The apparent MHC-restricted stimulation of B cells by 11.4 T  cells responding 
to B10.RIII B cells could be due to secretion of an MHC-restricted factor, but 
as we have already pointed out, this phenomenon may be explained by the action 
of nonspecific factors. 
Pathway of  B Cell Responses.  The results presented in this paper and the results 
of others suggest a more complicated view of B cell responses than is generally 
discussed. Each of the various events involved in causing a resting B cell to enter 
the cell cycle, to proliferate and to differentiate into an antibody-secreting cell, 
may be triggered by several different stimuli. For example, entry into G1 phase 
is clearly stimulated by anti-u, presumably by some antigens, and is also stimulated 
in an  MHC-unrestricted manner by antigen-stimulated T  cell lines as demon- 
strated here. This is also the step in the B cell response postulated to be controlled 
in  an  MHC-restricted manner, based  upon experiments showing that  large B 
cells from the spleen no longer need this signal (2). Since both anti-t~ and antigen- 
stimulated T  cells can each cause virtually all resting B cells to enlarge, these two 
signals would seem to  represent parallel  pathways of activation.  If an  MHC- 
restricted signal does exist, it may represent a third parallel pathway. Although 
B  cells may be activated by each of these stimuli,  it  is  not clear whether the 
consequences of the activation process is the same in each case. Detailed exami- 
nation of the properties of G1 phase B cells resulting from distinct stimuli will be 
required  to  determine the  equivalence or  lack of equivalence of the various 
stimuli. 
The value of experiments such as the ones reported here is to point out the 
nature of the steps in the B cell response caused by stimulated helper T  cells and 
thereby suggest  the  existence of presently unknown lymphokines with  novel 
functions.  Based  on  these experiments, we propose  the existence of a  B  cell 
activating factor that will act on a resting B cell and cause it to enter G~ phase in 
an MHC-unrestricted manner. 
Summary 
Resting B lymphocytes are activated, proliferate, and differentiate into anti- 
body-secreting cells when cultured with long-term lines of major histocompati- 
bility complex (MHC)-restricted, antigen-specific T  cell in the presence of the DEFRANCO ET  AL.  877 
antigen for which the T  cells are specific. Under optimal conditions, essentially 
all B cells are activated and ~35% enter S phase in the absence of antigens for 
which the B cells are specific. Activation and proliferation are observed in cells 
from both normal mice and mice with the xid-determined immune defect. Highly 
purified B  cells bearing Ia molecules for which the T  cells are "cospecific" can 
present antigen to T  cells with the resulting T  cell stimulation leading to the 
activation and proliferation of the antigen-presenting B cells. However, B cells 
that  do  not  bear  Ia  molecules  for  which  the  T  cells  are  cospecific  are  also 
activated and proliferate if antigen and a source of antigen-presenting B ceils or 
macrophage-rich cells of proper histocompatibility type are present. Thus, resting 
B cells, both normal and "xid', can be activated by non-MHC restricted factors 
without  receptor  cross-linkage.  Experiments  are  presented  that  support  the 
concept that local production and action of such unrestricted activating factors 
may be responsible for the MHC-restriction of T  cell-B cell interaction seen in 
many circumstances. 
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by William Leiserson and Linette Edison. 
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